Cool site pour acheter des pilules https://jacup.com/ Ne pas se perdre venir sur.
Abm clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012
Volume 7, Number 6, 2012ª Mary Ann Liebert, Inc.
ABM Clinical Protocol #15: Analgesia and Anesthesia
for the Breastfeeding Mother, Revised 2012
Anne Montgomery, Thomas W. Hale, and The Academy of Breastfeeding Medicine
A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing commonmedical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breast-feeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care.
Variations in treatment may be appropriate according to the needs of an individual patient.
amine the evidence currently available and make recom-mendations for prudent practice.
Labor, birth, and breastfeeding initiation compose a There is even less information in the scientific literature
normal, continuous process. Oxytocin, endorphins, and
about anesthesia for surgery in breastfeeding mothers. Re-
adrenaline produced in response to the normal pain of labor
commendations in this area focus on pharmacologic proper-
may play significant roles in maternal and neonatal responses
ties of anesthetic agents and limited studies of milk levels and
to birth and early breastfeeding.1 Use of pharmacologic
agents for pain relief in labor and postpartum may improve
Quality of evidence for each recommendation, as defined
outcomes by relieving suffering during labor and allowing
by the U.S. Preventive Task Force, is noted in parentheses (I,
mothers to recover from birth, especially cesarean birth, with
minimal interference from pain. However, these methodsmay also affect the course of labor and the neurobehavioral
state of the neonate and have adverse effects on breastfeedinginitiation. Unfortunately, the literature in this area has not
1. Maternity care providers should initiate an informed
addressed this issue as a whole, integrated process.
consent discussion for pain management in labor
In the setting of labor and childbirth, we will use the fol-
during the prenatal period, well before the onset of
lowing definitions throughout this protocol:
labor. Risk discussion should include what is knownabout the effects of various modalities on the progress
Analgesia: modification of painful stimuli so that they,
of labor, risk of instrumented and cesarean delivery,
while still experienced, are not painful.
effects on the newborn, and possible breastfeeding
Anesthesia: total loss of sensation.
Epidural analgesia: use of epidural anesthetics and
2. Unmedicated, spontaneous vaginal birth with imme-
opioids to reduce the painful experience of labor.
diate, uninterrupted skin-to-skin contact leads to the
Epidural anesthesia: use of epidural anesthetics to
highest likelihood of baby-led breastfeeding initia-
eliminate sensation, as for cesarean section.
tion.2,3 Longer labors, instrumented deliveries, cesarean
Very few studies directly address the impact of various
section, and separation of mother and infant after birth
approaches to labor pain management on breastfeeding out-
may lead to higher risk of difficulty with breastfeeding
comes. Although there are some older trials in which women
initiation.4–6 Labor pain management strategies may
were randomized to analgesia versus no analgesia in labor,
affect these birth outcomes and secondarily affect
these studies are limited by both crossover and confounding.
breastfeeding initiation in addition to any direct effects
At present, such trials would not be considered ethical, so we
of the medications themselves.7 (II-1; II-2)
will not anticipate randomized controlled trials comparing
3. Women have differing levels of pain tolerance. Labor
breastfeeding outcomes for analgesia versus no analgesia in
pain may exceed a woman’s ability to cope or be
labor. We do have a few recent trials looking at breastfeeding
magnified by fear and anxiety. Suffering in labor may
outcomes with different techniques and dosages for epidural
lead to dysfunctional labors, poorer psychologic out-
analgesia; these trials used a case-control design to compare
comes, and increased risk of postpartum depression, all
patients who received an epidural with those who had no
of which may have a negative effect on breastfeeding.8,9
analgesia. The technology of epidural anesthesia, in particu-
Severe maternal physiologic stress in labor also causes
lar, is evolving quickly, so studies that are even a few years
physiologic stress for babies, which may affect their
old may not reflect current practices. This protocol will ex-
readiness to breastfeed at birth.10 (III)
4. Continuous support in labor, ideally by a trained doula,
e. When a mother has received intravenous or intra-
reduces the need for pharmacologic pain management
muscular narcotics for labor, mother and infant
in labor and decreases the rates of instrumented deliv-
should be given more skin-to-skin time to encourage
ery and cesarean section. An earlier meta-analysis
suggested that doulas also improve breastfeeding out-
9. Although many studies have shown that epidural an-
comes both in the immediate postpartum period and
algesia affects infant behavior,20 the effect of epidural
several weeks after birth, but an update to this meta-
analgesia on breastfeeding continues to be controver-
analysis did not find statistical differences in breast-
sial. Older case-control and cohort studies suggested
that breastfeeding rates were lower after epidural an-
5. Nonpharmacologic methods for pain management in
algesia, and another observational study found de-
labor such as hypnosis and acupuncture have been
creased breastfeeding rates with higher doses of
found effective in reducing labor pain.12 (I) Other
fentanyl.21 However, because these studies were not
methods that are used in some but not all countries
randomized, they also raise the question as to whether
such as psychoprophylaxis (e.g., Lamaze), intrader-
women who choose epidural analgesia may be less
mal and/or subcutaneous water injections for back
likely to continue breastfeeding.22 Hormonally, epidu-
pain, etc., appear to be safe and have no known ad-
ral analgesia has been shown to decrease oxytocin
verse neonatal effects. These methods may reduce the
levels during labor and to affect oxytocin and prolactin
need for pharmacologic interventions. Additional
levels on Day 2 postpartum.23 Practically, use of epi-
study of breastfeeding outcomes is needed for these
dural analgesia may affect labor outcomes such as an
increased use of instrumented delivery and postpartum
6. Evidence suggests that breastfeeding success is affect-
separation of mother and infant related to birth out-
ed by the behavior of the newborn. Depressed or de-
comes that may secondarily affect breastfeeding.
layed suckling, which can be caused by medications
Several recent trials have shown no differences in
given to mothers, can lead to delayed or suppressed
breastfeeding rates in women with epidural analgesia.
lactogenesis and risk of excess infant weight loss.14,15
These trials randomized women to different techniques
of epidural analgesia but used a case-control design to
7. Intrapartum intravenous fluids are often given in larger
compare them with women who did not have any
quantities when pharmacologic pain relief methods
analgesia for labor. One trial done in New York ran-
such as epidural analgesia or anesthesia are used. These
domized 177 multiparas who had previously breastfed
fluids can potentially lead to maternal engorgement,
to different doses of epidural analgesia and compared
affect birth weight and newborn weight loss,16 and
them to a selected group of women with no analgesia.
cause neonatal hyperglycemia and rebound hyper-
All of these women had vaginal births. There were no
differences in breastfeeding rates except in the group
8. Parenteral (intravenous, intramuscular) opiates used for
who received > 150 mcg of fentanyl.24 A larger trial
labor may block the newborn’s normal reflexes to
done in the United Kingdom randomized 1,054 pri-
suckle at the breast within the first hour after birth.17,18
miparas to different techniques of epidural analgesia
a. If opiates are used, shorter-acting opiates such as
and compared them to a selected group. These groups
fentanyl or sufentanil are preferred. Remifentanil is
differed in that the epidural groups included more
potent and has rapid onset and offset but can be
women with cesarean and instrumented deliveries.
associated with a high incidence of maternal apnea,
There was no statistically significant difference in
requiring increased monitoring. Its transfer in utero
breastfeeding initiation or continuation in these groups
except that the ‘‘control’’ women who had received
b. Meperidine/pethidine/morphine should generally
intravenous pethidine had lower rates of breastfeeding
not be used except in small doses less than 1 hour or
initiation.25 Another well-designed prospective cohort
more than 4 hours prior to anticipated delivery be-
study also showed no differences in breastfeeding rates
cause of greater incidence and duration of respira-
after epidural analgesia in a population with high
tory depression, cyanosis, and bradycardia in
breastfeeding rates and good breastfeeding support.26
In summary, epidural analgesia has subtle effects on
c. Nalbuphine, butorphanol, and pentazocine may be
infant behavior. Women who choose epidural analgesia
used for patients with certain opioid allergies or at
may differ from women who do not with respect to
increased risk of difficult airway management or re-
breastfeeding plans. Higher or repeated doses of med-
spiratory depression. These medications may, how-
ication in the epidural space may make a difference.
ever, interfere with fetal heart rate monitoring
Like many other aspects of breastfeeding, epidural an-
interpretation. Observe the mother and infant for
algesia likely has almost no effect on women who are
determined to breastfeed and have good support but
d. Both the dosing (especially multiple doses) and the
may be one more subtle challenge to women whose
timing of parenteral analgesics may lead to greater
intention to breastfeed is more vulnerable.
neonatal effects. For example, fentanyl administra-
a. If epidural analgesia is chosen, methods that mini-
tion within 1 hour of delivery or meperidine/pethi-
mize the dose of medication and minimize motor
dine administration between 1 and 4 hours prior to
block should be used. Doses of fentanyl > 150 lg
delivery is associated with more profound neonatal
should be avoided.23 Longer durations and repeat-
ed administration of epidural analgesia should be
avoided if possible, to minimize effect on labor
medication dose that is fully effective. Opioid analgesia
outcomes that may secondarily affect breastfeed-
postpartum may affect babies’ alertness and suckling
ing. Combined spinal-epidural analgesia and
vigor. However, when maternal pain is adequately
patient-controlled epidural analgesia may be
treated, breastfeeding outcomes improve.31,32 Mothers
should be encouraged to adequately control their pain,
b. When epidural analgesia has been used for labor,
especially after cesarean birth or severe perineal trauma
particular care to provide mothers with good
breastfeeding support and close follow-up after
a. Parenteral medications (may be intravenous or in-
postpartum hospitalization should be taken. (II-2)
10. There are minimal data concerning the effects on the
i. Meperidine/pethidine should be avoided due to
neonate of other labor anesthesia, including inhaled
reported neonatal sedation when given to breast-
nitrous oxide, paracervical block, pudendal block, and
feeding mothers postpartum,33 in addition to the
local perineal anesthesia.28 These modalities do not
concerns of cyanosis, bradycardia, and the risk of
usually expose the infant to significant quantities of
apnea that have been noted with intrapartum
medication. In some situations, these may serve as al-
ternatives to intravenous narcotics or epidural analgesia
ii. The administration of moderate to low doses of in-
for labor. Their use, however, is limited by several
travenous or intramuscular morphine is preferred to
factors. These include lack of efficacy, technical diffi-
meperidine/pethidine as passage to milk and oral
culties in performing, and a high rate of complications.
bioavailability are least with this agent.33,36
iii. When patient-controlled intravenous analgesia
(PCA) is chosen after cesarean section, morphine orfentanyl is preferred over meperidine/pethidine.32,37
1. Regional anesthesia (epidural or intrathecal/spinal) is
iv. Levels of butorphanol in human milk have been
preferred over general anesthesia. Separation of a
reported with approximately 0.5% of the weight-
mother and her infant should be minimized, and
adjusted maternal dose* transferred into human
breastfeeding should be initiated as soon as feasible.29
milk. These appear minimal and probably are of
In fact, the infant may go to the breast in the operating
no concern to a breastfeeding neonate in the first
room during abdominal closure with assistance to
week postpartum. The use of butorphanol during
support the infant on the mother’s chest. If breastfeed-
labor has been reported to produce sinusoidal fetal
ing is initiated in the recovery room, there is the added
heart rate patterns and irritability in newborns.
advantage that the incision is often still under the in-
v. Levels of nalbuphine in human milk are quite low.
In one study the levels of nalbuphine in milk av-
2. A mother who has had general anesthesia may breast-
erage only 42 lg/L with an estimated weight-
feed postoperatively as soon as she is alert enough to
adjusted relative infant dose (RID) of 0.59%.38
hold the infant and is not overly sedated. (III)
vi. Hydromorphone (approximately seven to 11 times
as potent as morphine) is sometimes used forextreme pain in a PCA, intramuscularly, intrave-
nously, or orally. Following a 2 mg intranasal
1. Non-opioid analgesics should generally be the first
dose, levels in milk were quite low with a weight-
choice for pain management in breastfeeding postpar-
adjusted RID of about 0.67%.39 This correlates with
tum women, as they do not impact maternal or infant
about 2.2 lg/day via milk. This dose is probably
too low to affect a breastfeeding infant, but this is a
a. Acetaminophen/paracetamol and ibuprofen are safe
strong opioid, and some caution is recommended.
and effective for analgesia in postpartum mothers.
b. Ketorolac is commonly used for postpartum anal-
i. Hydrocodone has been used frequently in breast-
gesia, especially after cesarean section, despite a
feeding mothers worldwide. Less than 3.7% of the
Food and Drug Administration black box warning
weight-adjusted maternal dose (RID) reaches the
(in the United States) against the use of this medicine
infant per day. Higher doses (10 mg of hydro-
for breastfeeding women.30 Milk levels after oral
codone) and/or more frequent administration may
administration are quite low, but levels have not
lead to neonatal sedation and should be used with
been measured after parenteral administration.
c. Diclofenac suppositories are available in some
ii. Recent cases have raised concern about the use of
countries and commonly used for postpartum anal-
codeine. Some mothers may rapidly metabolize
gesia. Milk levels are extremely low.
d. Cyclooxygenase-2 inhibitors such as celecoxib may
have some theoretical advantages if maternal bleeding
*An important concept when discussing the risk of maternal
is a concern; this must be balanced with higher cost and
medications to the breastfeeding infant is that of the relative infant
possible cardiovascular risks, which should be minimal
dose. It is imperative to understand that this is a value that is cal-
with short-term use in healthy young women.19
culated by dividing the infant’s dose from the milk in mg/kg/dayby the mother’s dose in mg/kg/day. In this manner of calculation, a
2. Both pain and opioid analgesia can have a negative
weight-normalized dose is determined that the baby may receive,
impact on breastfeeding outcomes; thus mothers should
which is more accurate than when one does not take the weight of
be encouraged to control their pain with the lowest
the mother and the baby into account.
codeine to morphine, which can lead to toxic levels
are low once mothers resume normal mentation. For
of morphine in the infant. Codeine should be used
maternal safety, regional anesthesia is recommended for
with caution, although it is probably safe in the
this procedure in preference to general anesthetic. (III)
3. Mothers who have undergone dental extractions or
iii. Several studies now suggest that oxycodone may
other procedures requiring the use of single doses of
be useful in some patients postpartum. Less than
medication for sedation and analgesia can breastfeed as
3.5% of the weight-adjusted maternal dose (RID)
soon as they are awake and stable. Although shorter-
transfers into human milk. Prolonged and frequent
acting agents such as fentanyl and midazolam may be
administration may lead to neonatal sedation.41
preferred, single doses of meperidine/pethidine or dia-
There is also the rare mother who is an ultrarapid
zepam are unlikely to affect the breastfeeding infant.42 (III)
metabolizer, whose babies are at higher risk for
4. Mothers who have undergone plastic surgery, such as
central nervous system depression [see Analgesics
liposuction, where large doses of local anesthetics
(lidocaine/xylocaine or lignocaine) have been used
iv. Several recent studies of buprenorphine suggest
should probably pump and discard their milk for 12
that approximately 1.9% of the weight-adjusted
hours prior to resuming breastfeeding. (III)
maternal dose is transferred to the infant daily.
5. The maternal dose and the ability of the infant to clear
Buprenorphine has a long half-life and should be
small amounts of medications that can cause cardiore-
used with some caution in infants who have not
spiratory effects is of primary concern before returning
been previously exposed to the drug. Mothers
to breastfeeding. Infants subject to apnea, hypotension,
treated continually for addiction may continue to
or hypotonia should probably be protected by a few
breastfeed using this medication as long as the
more hours of interruption from breastfeeding (12–24
infant is tolerant to the current dose.42
i. Single-dose opioid medications (e.g., neuraxial
morphine) should have minimal effects on breast-
feeding because of negligible maternal plasmalevels achieved. Extremely low doses of morphine
1. Drugs used for anesthetic induction such as propofol,
ii. Continuous post-cesarean epidural infusion may
midazolam, etomidate, or thiopental enter the milk
be an effective form of pain relief that minimizes
compartment only minimally, as they have extraordi-
opioid exposure. A randomized study that com-
narily brief plasma distribution phases (only minutes),
pared spinal anesthesia for elective cesarean with
and hence their transport to milk is low to nil.45–48
or without the use of postoperative extradural
2. Little or nothing has been reported about the use of
continuous bupivacaine found that the continuous
anesthetic gases in breastfeeding mothers. However,
group had lower pain scores and a higher volume
they too have brief plasma distribution phases, and
milk levels are likely nil. A recent series of case reportssuggests that xenon maintenance after propofol induction
allows for breastfeeding immediately after surgery.49
3. The use of ketamine in breastfeeding mothers is unre-
ported. Following the use of ketamine, many adult
1. The implications of drugs used in anesthesia in post-
patients may exhibit dissociative anesthetic effects. This
partum mothers depend on numerous factors, including
is often suppressed with the addition of midazolam or
the age of the infant, the stability of the infant, the length
other benzodiazepines. The emergent reactions are ap-
of lactation, and the ability of the infant to clear small
parently age-dependent and appear to occur more fre-
quantities of anesthetic medications.43 Anesthetic agents
quently in adults (30–50%) and less frequently in
will have little or no effect on older infants but could
potentially cause problems in newborn infants, particu-
4. For specific local anesthetics for epidural use (such as
larly those who are premature or suffer from apnea. (III)
bupivacaine and ropivacaine), see general comments
2. Mothers with normal term or older infants can gener-
about epidural analgesia/anesthesia. These and other
ally resume breastfeeding as soon as they are awake,
local anesthetics are poorly absorbed orally so should be
stable, and alert. Resumption of normal mentation is a
safe in postpartum breastfeeding mothers. Milk levels of
hallmark that these medications have redistributed
bupivacaine and ropivacaine51 are exceedingly low.
from the plasma compartment (and thus generally themilk compartment) and entered adipose and muscletissue where they are slowly released. The exception
could be a drug that is highly lipid soluble, in which
breast tissue may function as a fat compartment, actingas a drug reservoir. For women who undergo post-
a. Morphine is still considered an ideal analgesic for
partum tubal ligation, interruption of breastfeeding is
breastfeeding mothers due to its limited transport to
not indicated as the volume of colostrum is small; hence
milk and its poor oral bioavailability in infants.33,37
the dose to the infant is low as well.44 In addition, the
b. The transfer of meperidine/pethidine into breast-
levels of medication in the maternal plasma and milk
milk is low (1.7–3.5% of maternal weight-adjusted
dose). However, meperidine/pethidine and its
2. Non-steroidal anti-inflammatory drug analgesics
metabolite (normeperidine) are consistently associ-
Use of non-steroidal anti-inflammatory drugs (NSAIDs)
ated with dose-related neonatal sedation. Transfer
alone after vaginal birth or in combination with opioids
into milk and neonatal sedation have been docu-
after cesarean birth can improve pain control by as-
mented for even up to 36 hours after a single dose.33
sisting with some of the pain due to uterine cramping.
Meperidine/pethidine should be avoided during
NSAIDs are generally safe for breastfeeding and can
labor and in postpartum analgesia (except, perhaps,
help minimize the total dose of opioid needed to control
within 1 hour prior to delivery). Infants of mothers
who have been exposed to repeated doses of meper-
a. Ibuprofen is considered an ideal, moderately effec-
idine/pethidine should be closely monitored for se-
tive analgesic. Its transfer to milk is low to nil.56
dation, cyanosis, bradycardia, and possibly seizures.
b. Ketorolac is a potent analgesic in breastfeeding
c. Although there are no published data on re-
mothers and is increasingly popular when used
mifentanil, this esterase-metabolized opioid has a
postpartum. Its primary benefit is excellent analge-
brief half-life even in infants ( < 10 minutes) and has
sia, with no sedative properties. In addition, the
been documented to produce no fetal sedation even
transfer of ketorolac into milk is extremely low.57
in utero. Although its duration of action is limited, it
However, its use in postsurgical patients with hem-
could be used safely and indeed may be ideal in
orrhage may be somewhat risky as it inhibits platelet
breastfeeding mothers for short painful procedures.
function, although this is somewhat controversial. It
d. Fentanyl levels in breastmilk have been studied and
should not be used in patients with a history of
are extremely low after 2 hours and generally below
gastritis, aspirin allergy, or renal insufficiency. If
there is no risk of hemorrhage, it carries few com-
e. Sufentanil transfer into milk has not been published,
plications for breastfeeding mothers and their in-
but it should be similar to that of fentanyl.
fants. However, the Food and Drug Administration
f. Nalbuphine and butorphanol levels in breastmilk are
now has a black box warning against use of ketorolac
very low. At this time they would only be indicated
in the specific situations mentioned previously. If
c. Celecoxib transfer into milk is extraordinarily low
these agents are used, observe the mother and infant
( < 0.3% of the weight-adjusted maternal dose).58 Its
g. Hydrocodone has been used frequently in breast-
d. Naproxen transfer into milk is low, but gastrointes-
feeding mothers. Occasional cases of neonatal seda-
tinal disturbances have been reported in some in-
tion have been documented, but these are rare and
fants following prolonged therapy. Short-term use (1
generally dose related. Doses in breastfeeding
mothers should be kept at the minimum necessary tocontrol pain. Frequent dosing throughout the day
may lead to sedative effects in the breastfed infant.
h. A recent report of a neonatal death following the use
1. Studies of labor analgesia and anesthesia for cesarean
of codeine suggests that the use of codeine in breast-
section should specifically study breastfeeding outcomes.
feeding mothers should be monitored closely.54 Al-
Although randomization of analgesia versus no analgesia
though rare, rapid metabolizers of codeine are known,
is not possible, good prospective study designs should
and levels of morphine following the use of codeine
allow appropriate comparisons and should help describe
may be significantly elevated thus putting the infant at
appropriate support for breastfeeding mothers and in-
risk. Use caution with codeine in breastfeeding mothers.
fants who have been exposed to labor analgesia.
i. Oxycodone levels in milk are known and average ap-
2. More study of specific breastfeeding outcomes after
proximately 58 lg/L (range, 7–130 lg/L) (RID = 1.5–
surgical anesthesia in breastfeeding mothers is needed.
3.5%). Oxycodone may not be significantly safer for the
3. More data on the use of ketorolac as it has gained in
rare mother who is an ultrarapid metabolizer, as it is
popularity in the postpartum period are needed.
also a substrate for CYP2D6. A recent retrospective
4. More study is required of the special needs of prema-
study showed that one in five breastfed infants with
ture and unstable babies including how their ability to
mothers medicated with oxycodone experienced cen-
clear maternal anesthetic and analgesic drugs may dif-
tral nervous system depression. The strong concor-
dance between maternal and infant symptoms may beused to identify babies at higher risk. It is important to
follow these infants carefully for drowsiness.55
j. Regardless of the opioid, always consider the dose
This work was supported in part by a grant from the Ma-
used. Many mothers undergoing chronic pain thera-
ternal and Child Health Bureau, U.S. Department of Health
py in various pain clinics may use exceedingly high
doses of hydrocodone, oxycodone, methadone, andother opioid analgesics. Those infants of mothers with
exceedingly high doses should be closely monitored
1. Smith L. Impact of Birthing Practices on Breastfeeding, 2nd
for sedation and apnea. If the infants are exposed in
ed. Jones and Bartlett Publishers, Sudbury, MA, 2010.
utero, the risk, initially, is probably somewhat less
2. Righard L, Alade MO. Effect of delivery room routines on
success of first breast-feed. Lancet 1990;336:1105–1107.
3. Widstrom AM, Liilja G, Aaltomaa-Michalias, et al. Newborn
24. Bielin Y, Bodian CA, Weiser J, et al. Effect of labor epidu-
behavior to locate the breast when skin-to-skin: A possible
ral analgesia with and without fentanyl on infant breast-
method for enabling early self-regulation. Acta Paediatr 2011;
feeding. Anesthesiology 2005;103:1200–1207.
25. Wilson MJA, MacArthur C, Cooper GM, et al. Epidural
4. Rajan L. The impact of obstetric procedures and analgesia/
analgesia and breastfeeding: A randomized controlled trial
anaesthesia during labour and delivery on breast feeding.
of epidural techniques with and without fentanyl and a
non-epidural comparison group. Anaesthesia 2010;65:145–
5. Tamminen T, Verronen P, Saarikoski S, et.al. The influence
of perinatal factors on breast feeding. Acta Paediatr Scand
26. Halpern SH, Levine T, Wilson DB, et al. Effect of labor an-
algesia on breastfeeding success. Birth 1999;26:83–88.
6. Patel RR, Liegling RE, Murphy DJ. Effect of operative de-
27. Loubert C, Hinova A, Fernando R. Update on modern
livery in the second stage of labor on breastfeeding success.
neuraxial analgesia in labour: A review of the literature of
the last 5 years. Anaesthesia 2011;66:191–212.
7. Howell CJ. Epidural versus non-epidural or no analgesia for
28. Stefani SJ, Hughes SC, Shnider SM, et al. Neonatal neuro-
pain relief in labour. Cochrane Database Syst Rev 2005;(4):
behavioral effects of inhalation analgesia for vaginal deliv-
ery. Anesthesiology 1982;56:351–355.
8. Ferber SG, Ganot M, Zimmer EZ. Catastrophizing labor pain
29. Mathur GP, Pandey PK, Mathur S, et al. Breastfeeding in
compromised later maternity adjustments. Am J Obstet Gy-
babies delivered by cesarean section. Indian Pediatr 1993;30:
9. Hiltunen P, Raudaskoski T, Ebeling H, et al. Does pain relief
30. Drugs and lactation database (LactMed). U.S. National
during delivery decrease the risk of postnatal depression?
Library of Medicine, TOXNET Toxicology Data Network.
Acta Obstet Gyencol Scand 2004;83:257–261.
10. Reynolds F. Labour analgesia and the baby: Good news is
*bYSp38:1 (accessed October 18, 2012).
no news. Int J Obstet Anesth 2011;20:38–50.
31. Hirose M, Hara Y, Hosokawa T, et al. The effect of postop-
11. Hodnett ED, Gates S, Hofmeyr GJ, et al. Continuous support
erative analgesia with continuous epidural bupivacaine after
for women during childbirth. Cochrane Database Syst Rev
cesarean section on the amount of breast feeding and infant
weight gain. Anesth Analg 1996;82:1166–1169.
12. Smith CA, Collins CT, Cyna AM, et al. Complementary and
32. Gadsden J, Hart S, Santos A. Post-cesarean delivery anal-
alternative therapies for pain management in labour.
gesia. Anesth Analg 2005;101(5 Suppl):S62–S69.
Cochrane Database Syst Rev 2006;(4):CD003521.
33. Wittels C, Scott DT, Sinatra RS. Exogenous opioids in human
13. Simkin PP, O’Hara MA. Nonpharmacologic relief of pain
breast milk and acute neonatal neurobehavior: A prelimi-
during labor: Systematic reviews of five methods. Am J
nary study. Anesthesiology 1990;73:864–869.
Obstet Gynecol 2002;186(5 Suppl Nature):S131–S159.
34. Hamza J, Benlabed M, Orhant E, et al. Neonatal pattern of
14. Mizuno K, Fujimaki K, Sawada M. Sucking behavior at breast
breathing during active and quiet sleep after maternal ad-
during the early newborn period affects later breast-feeding
ministration of meperidine. Pediatr Res 1992;3:412–416.
rate and duration of breast-feeding. Pediatr Int 2004;46:15–20.
35. Hodgkinson R, Bhatt M, Grewal G, et al. Neonatal neuro-
15. Dewey KG, Nommsen-Rivers LA, Heinig MJ, et al. Risk
behavior in the first 48 hours of life: Effect of the adminis-
factors for suboptimal infant breastfeeding behavior, de-
tration of meperidine with and without naloxone in the
layed onset of lactation, and excess neonatal weight loss.
mother. Pediatrics 1978;62:294–298.
36. Feilberg VL, Rosenborg D, Broen CC, et al. Excretion of
16. Chantry CJ, Nommsen-Rivers LA, Peerson JM, et al. Excess
morphine in human breast milk. Acta Anaesthesiol Scand
weight loss in first-born breastfed newborns relates to ma-
ternal intrapartum fluid balance. Pediatrics 2010;127:e171.
37. Wittels B, Glosten B, Faure E, et al. Postcesarean analgesia
17. Ransjo-Arvidson AB, Matthiesen SA, Lilja G, et al. Maternal
with both epidural morphine and intravenous patient-
analgesia during labor disturbs newborn behavior: Effects on
controlled analgesia: Neurobehavioral outcomes among
breastfeeding, temperature, and crying. Birth 2001;28:5–12.
nursing neonates. Anesth Analg 1997;85:600–606.
18. Nissen E, Lilja G, Matthiesen A-S, et al. Effects of maternal
38. Jacqz-Aigrain E, Serreau R, Boissinot C, et al. Excretion of
pethidine on infants’ developing breast feeding behaviour.
ketoprofen and nalbuphine in human milk during treatment
of maternal pain after delivery. Ther Drug Monit 2007;29:
19. Hale TW. Medications and Mothers’ Milk, 14th ed. Hale
39. Edwards JE, Rudy AC, Wermeling DP, et al. Hydro-
20. Chang ZM, Heaman ML. Epidural analgesia during labor
morphone transfer into breast milk after intranasal admin-
and delivery: Effects on the initiation and continuation of
istration. Pharmacotherapy 2003;23:153–158.
effective breastfeeding. J Hum Lact 2005;21:305–314.
40. Madadi P, Koren G, Carns J, et al. Safety of codeine during
21. Jordan S, Emery S, Bradshaw C, et al. The impact of intra-
breastfeeding. Can Fam Physician 2007;53:33–35.
partum analgesia on infant feeding. BJOG 2005;112:927–934.
41. Marx CM, Pucin F, Carlson JD, et al. Oxycodone excretion in
22. Torvaldsen S, Roberts CL, Simpson J, et al. Intrapartum
human milk in the puerperium [abstract]. Drug Intel Clin
epidural analgesia and breastfeeding: A prospective cohort
42. Grimm D, Pauly E, Poschl J, et al. Buprenorphine and nor-
23. Jonas W, Johansson LM, Nissen E., et al. Effects of in-
buprenorphine concentrations in human breast milk sam-
trapartum oxytocin administration and epidural analgesia
ples determined by liquid chromatography-tandem mass
on the concentration of plasma oxytocin and prolactin, in
spectrometry. Ther Drug Monit 2005;27:526–530.
response to suckling during the second day postpartum.
43. Hale TW. Anesthetic medications in breastfeeding mothers.
44. Rathmell JP, Viscomi CM, Ashburn MA. Management of
55. Lam J, Kelly L, Ciskowski C, et al. Central nervous system
nonobstetric pain during pregnancy and lactation. Anesth
depression of neonates breastfed by mothers receiving oxy-
codone for postpartum analgesia. J Pediatr 2012;160:33–
45. Andersen LW, Qvist T, Hertz J, et al. Concentrations of
thiopentone in mature breast milk and colostrum following
56. Weibert RT, Townsend RJ, Kaiser DG, et al. Lack of ibu-
an induction dose. Acta Anaesthesiol Scand 1987;31:30–32.
profen secretion into human milk. Clin Pharm 1982;1:457–
46. Matheson I, Lunde PK, Bredesen JE. Midazolam and ni-
trazepam in the maternity ward: Milk concentrations and
57. Wischnik A, Manth SM, Lloyd J, et al. The excretion of ke-
clinical effects. Br J Clin Pharmacol 1990;30:787–793.
torolac tromethamine into breast milk after multiple oral
47. Dailland P, Cockshott ID, Lirzin JD, et al. Intravenous pro-
dosing. Eur J Clin Pharmacol 1989;36:521–524.
pofol during cesarean section: Placental transfer, concentra-
58. Hale TW, McDonald R, Boger J. Transfer of celecoxib into
tions in breast milk, and neonatal effects. A preliminary
human milk. J Hum Lact 2004;20:397–403.
study. Anesthesiology 1989;71:827–834.
59. Jamali F, Stevens DR. Naproxen excretion in milk and its
48. Schmitt JP, Schwoerer D, Diemunsch P, et al. Passage of
uptake by the infant. Drug Intell Clin Pharm 1983;1:910–1911.
propofol in the colostrum. Preliminary data. Ann Fr AnesthReanim 1987;6:267–268.
ABM protocols expire 5 years from the date of publication.
49. Stuttmann R, Schafer C, Hilbert P, et al. The breast feeding
Evidence-based revisions are made within 5 years or sooner if
mother and xenon anaesthesia: Four case reports. BMC
there are significant changes in the evidence.
50. Bergman SA. Ketamine: Review of its pharmacology and its
Academy of Breastfeeding Medicine Protocol Committee
use in pediatric anesthesia. Anesth Prog 1999;46:10–20.
Kathleen A. Marinelli, M.D., FABM, Chairperson
51. Matsota PK, Markantonis SL, Fousteri MZ, et al. Excretion of
Maya Bunik, M.D., MSPH, FABM, Co-Chairperson
ropivacaine in breast milk during patient-controlled epidu-
Larry Noble, M.D., FABM, Translations Chairperson
ral analgesia after cesarean delivery. Reg Anesth Pain Med2009;34:126–129.
52. Leuschen MP, Wolf LJ, Rayburn WF. Fentanyl excretion in
breast milk. Clin Pharm 1990;9:336–337.
53. Madej TH, Strunin L. Comparison of epidural fentanyl with
sufentanil. Analgesia and side effects after a single bolus dose
during elective caesarean section. Anaesthesia 1987;42:1156–1161.
54. Koren G, Cairns J, Chtayat D, et al. Pharmacogenetics of
morphine poisoning in a breastfed neonate of a codeineprescribed mother. Lancet 2006;368:704.
LEAVING CERTIFICATE BIOLOGY HIGHER LEVEL EXAM PAPER SOLUTIONS Sample Paper 4 Section A Question 1 a) D: Zone of Differentiation/C: Zone of Elongation/A: Root Cap/B: Meristem 4(1)New Tissues: Zone of Differentiation/Mitosis: Meristem/Growth Regulators: Zone ofElongation/Absorbtion of water: Zone of Differentiation 4(1)(i) A: Vascular bundle/B: Air Spaces/C: Guard Cells/D: Stoma 4(1).
DAILY BIBLE READING SCHEDULE YEAR 2009 Holy Cross Lutheran Church Indianapolis Indiana YEAR 2009 DAILY BIBLE READINGS The Holy Bible is a great treasure through which God Himself speaks to us! This schedule is one year of a program to read the entire Bible in 2 years, while including all the major teachings of the Bible each year. The following Bible books coveri